Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors
The Long Run with Luke Timmerman ›56:23 | Aug 6th
Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.
56:23 | Aug 6th
Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.
🎉 Join the #1 community of podcast lovers and never miss a great podcast.
Sign up
Recommendations